• AXIS Clinicals successfully completes 20th US FDA audit (April 2017)
  • AXIS Clinicals successfully completes MCC South Africa audit (March 2017)
  • AXIS Clinicals successfully completes GCC audit (February 2016)
  • AXIS Clinicals successfully completes 7th ANVISA – Brazil audit (March 2015)
  • AXIS Clinicals successfully completes WHO audit (March 2015)
  • AXIS Clinicals successfully completes 3rd MHRA audit (Sep 2014)
  • BA-BE studies conducted at AXIS Clinicals are accepted by Chile – ISP

Global Locations

India :
The operations in India has been running since 2004, providing expert, innovative clinical services and solutions for customers. Our office houses approx. 500 people including highly trained clinical research professionals, project managers, and skilled Bio-Analytical scientists. With dedicated PK/Statistics and Clinical Data Management team, the company offers end-to-end solution to customers. AXIS Clinicals has a total floor area of approximately 210000 sft in India. at its Indian facility that houses approx. 700+ beds and 50+ modern LC/MS-MS systems.

Contact:
Mr. Abhijit Chaudhari
Director – Business Development
AXIS Clinicals Limited
1-121/1, Survey No.66 (Part) & 67(Part),
Miyapur, Serilingampally, Hyderabad
Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.


United States :

AXIS Clinicals LLC is located at Dilworth (Minnesota). We  offer the following specialized services to our client’s in addition to regular BA/BE studies:

  • Dermal PK (safety and efficacy studies)
  • Dermal adhesion (FDA Standard and Dot Adhesion models)
  • Cumulative irritation and HRIPT studies
  • Dermatopharmacokinetic (DPK) tape stripping studies (often driven by protocol requirements)
  • Vasoconstriction studies
Contact:
Mr. Sidharth Mishra
Vice President – Business Development and Project Management (U.S)
AXIS Clinicals Ltd.
1711 Highway 10 East, Dilworth,
Minnesota, U.S.A
Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.


Mexico :

AXIS, Latina started operations in 2011 and equipped with 130 beds in +40,000 sq. ft. clinic area and the Bio-Analytical lab is equipped with four modern LC/MS-MS systems. With +70 people team at Mexico, we are catering to the clinical development needs of major local and international generic players for registration of their products in Mexican and other Latin American market.

Contact:
Mr. Sagar Sarode 
Senior Manager – Business Development
AXIS Clinicals Latina.
Ing. Basiliso Romo Anguiano,
225 Col. Gpe. Insurgentes, Del. G.A. Madero; C.P. 07870,
México D.F., MÉXICO
Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

 

 

Fact sheet

  • 2,400+ clinical studies completed since inception
  • 350+ bioanalytical methods developed
  • 50+ successful Regulatory audits
  • Global footprint of operations with sites in India, U.S & Mexico.
  • Two clinical facilities (Hyderabad & Ahmedabad) in India
  • 100+ National and International Pharma/Biotech Sponsor companies working with AXIS
  • US FDA : 500+ approvals, EMEA : 100+ approvals, Canada : 50+ approvals, Australia : 50+ approvals
  • 500+ experianced employees working globally
  • Huge database of patient population in various therapeutic areas viz. Cardiology, Opthalmology, Schizophrenia, Diabetology, Oncology. Orthopedics etc..

Copyright Axis Clinicals - All Rights Reserved